|
|
|
Do antiseptic coated central lines prevent catheter-related bloodstream infection?
Lead author's name: Pemberton LB
Three-part Clinical Question: Patients: surgical patients having TPN Intervention: antiseptic impregnation with silver sulphadiazine and chlorhexidine or untreated central venous catheters Outcomes: catheter colonisation and catheter related bloodstream infection (CRBSI)
Search Terms: intensive care, critical care, central venous catheters, infection, prevention, controlled trial
The Study: Randomised, controlled trial, without intention-to treat analysis
The Study Patients: 88 catheters, 72 were evaluable
Control group (standard CVC) n=40 Experimental group (impregnated CVC) n=32
The Evidence:
EBM questions:
1) Do the methods allow accurate testing of the hypothesis? No, because of a potential type II error
2) Do the statistical tests correctly test the results to allow differentiation of statistically significant results? No, because of a potential type II error. No power calculation was made
3) Are conclusions valid in light of the results? Yes.
4) Did results get omitted, and why? Yes, 16 patients were excluded from analysis because their catheters were not cultured.
5) Did they suggest areas of further research? Yes – the need for larger RCTs
6) Did they make any recommendations based on the results and were they appropriate? No
7) Is the study relevant to my clinical practice? Perhaps, the patients were not intensive care patients, but surgical patients on TPN.
8) What level of evidence does this study represent? 1-
9) What grade of recommendation can I make on this result alone? N/A
10) What grade of recommendation can I make when this study is considered along with other available evidence? A - see topic summary.
11) Should I change my practice because of these results? Perhaps- it depends on your views about the validity and importance of pooled analysis of RCTs
12) Should I audit my current practice because of these results? No, but you should be auditing CRBSI rates anyway.
Appraised by Dr David Swann, Consultant, ICU, Royal Infirmary of Edinburgh. June 2005
Email: d.g.swann@ad.ac.uk
Edited by CC Kill by Date: 2010
©SICS EBMG 2002
| |||||||||||||||||||||||